Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Interleukin 2 Receptor Subunit Alpha market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Interleukin 2 Receptor Subunit Alpha are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Interleukin 2 Receptor Subunit Alpha market segmented into
DEL-106
MDNA-209
NKTR-358
APT-602
Others

Based on the end-use, the global Interleukin 2 Receptor Subunit Alpha market classified into
Autoimmune Disorders
Blood Cancer
Ovarian Cancer
Renal Cell Carcinoma
Others

Based on geography, the global Interleukin 2 Receptor Subunit Alpha market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
AbbVie Inc.
Alkermes Plc
APT Therapeutics, Inc.
Mabtech Limited
Philogen S.p.A.

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA INDUSTRY
2.1 Summary about Interleukin 2 Receptor Subunit Alpha Industry
2.2 Interleukin 2 Receptor Subunit Alpha Market Trends
2.2.1 Interleukin 2 Receptor Subunit Alpha Production & Consumption Trends
2.2.2 Interleukin 2 Receptor Subunit Alpha Demand Structure Trends
2.3 Interleukin 2 Receptor Subunit Alpha Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 DEL-106
4.2.2 MDNA-209
4.2.3 NKTR-358
4.2.4 APT-602
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Autoimmune Disorders
4.3.2 Blood Cancer
4.3.3 Ovarian Cancer
4.3.4 Renal Cell Carcinoma
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 DEL-106
5.2.2 MDNA-209
5.2.3 NKTR-358
5.2.4 APT-602
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Autoimmune Disorders
5.3.2 Blood Cancer
5.3.3 Ovarian Cancer
5.3.4 Renal Cell Carcinoma
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 DEL-106
6.2.2 MDNA-209
6.2.3 NKTR-358
6.2.4 APT-602
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Autoimmune Disorders
6.3.2 Blood Cancer
6.3.3 Ovarian Cancer
6.3.4 Renal Cell Carcinoma
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 DEL-106
7.2.2 MDNA-209
7.2.3 NKTR-358
7.2.4 APT-602
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Autoimmune Disorders
7.3.2 Blood Cancer
7.3.3 Ovarian Cancer
7.3.4 Renal Cell Carcinoma
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 DEL-106
8.2.2 MDNA-209
8.2.3 NKTR-358
8.2.4 APT-602
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Autoimmune Disorders
8.3.2 Blood Cancer
8.3.3 Ovarian Cancer
8.3.4 Renal Cell Carcinoma
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 DEL-106
9.2.2 MDNA-209
9.2.3 NKTR-358
9.2.4 APT-602
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Autoimmune Disorders
9.3.2 Blood Cancer
9.3.3 Ovarian Cancer
9.3.4 Renal Cell Carcinoma
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AbbVie Inc.
10.1.2 Alkermes Plc
10.1.3 APT Therapeutics, Inc.
10.1.4 Mabtech Limited
10.1.5 Philogen S.p.A.
10.2 Interleukin 2 Receptor Subunit Alpha Sales Date of Major Players (2017-2020e)
10.2.1 AbbVie Inc.
10.2.2 Alkermes Plc
10.2.3 APT Therapeutics, Inc.
10.2.4 Mabtech Limited
10.2.5 Philogen S.p.A.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Interleukin 2 Receptor Subunit Alpha Product Type Overview
2.Table Interleukin 2 Receptor Subunit Alpha Product Type Market Share List
3.Table Interleukin 2 Receptor Subunit Alpha Product Type of Major Players
4.Table Brief Introduction of AbbVie Inc.
5.Table Brief Introduction of Alkermes Plc
6.Table Brief Introduction of APT Therapeutics, Inc.
7.Table Brief Introduction of Mabtech Limited
8.Table Brief Introduction of Philogen S.p.A.
9.Table Products & Services of AbbVie Inc.
10.Table Products & Services of Alkermes Plc
11.Table Products & Services of APT Therapeutics, Inc.
12.Table Products & Services of Mabtech Limited
13.Table Products & Services of Philogen S.p.A.
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Interleukin 2 Receptor Subunit Alpha Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Interleukin 2 Receptor Subunit Alpha Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Interleukin 2 Receptor Subunit Alpha Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Interleukin 2 Receptor Subunit Alpha Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Interleukin 2 Receptor Subunit Alpha Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Interleukin 2 Receptor Subunit Alpha Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Interleukin 2 Receptor Subunit Alpha Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Interleukin 2 Receptor Subunit Alpha Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Interleukin 2 Receptor Subunit Alpha Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Interleukin 2 Receptor Subunit Alpha Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Interleukin 2 Receptor Subunit Alpha Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure DEL-106 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure MDNA-209 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure NKTR-358 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure APT-602 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Renal Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure DEL-106 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure MDNA-209 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure NKTR-358 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure APT-602 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Renal Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure DEL-106 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure MDNA-209 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure NKTR-358 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure APT-602 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Renal Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure DEL-106 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure MDNA-209 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure NKTR-358 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure APT-602 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Blood Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Renal Cell Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure DEL-106 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure MDNA-209 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure NKTR-358 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure APT-602 Segmentation Market Size (US

Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...

Alpha-Fetoprotein (AFP) Biomarker Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Alpha-Fetoprotein (AFP) Biomarker Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) ...

Executive Summary Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...

Global Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class (ERA, TGF-β Ligand, sGC Stimulators, IP Receptor Agonists, Others), Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonis...

2023-2028 Global and Regional G-Protein Coupled Receptor (GPCR) Targeting Industry Status and Prospects Professional Market Research Report Standard Version...

The global G-Protein Coupled Receptor (GPCR) Targeting market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help...

2023-2028 Global and Regional Alpha-Adrenoreceptor Antagonists Industry Status and Prospects Professional Market Research Report Standard Version...

The global Alpha-Adrenoreceptor Antagonists market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...

2023-2028 Global and Regional Interleukin Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Interleukin Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...

2023-2028 Global and Regional Interferon Alpha-2a Biosimilar Industry Status and Prospects Professional Market Research Report Standard Version...

The global Interferon Alpha-2a Biosimilar market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...

2023-2028 Global and Regional Human Interleukin-2 (IL-2) Industry Status and Prospects Professional Market Research Report Standard Version...

The global Human Interleukin-2 (IL-2) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Recombinant Human Interleukin Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Human Interleukin market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...